Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
6th grade Avg
|
|
New words:
Accrued, adequate, American, ankylosing, assessed, assessment, assurance, Biopharmaceutical, bortezomib, Celebrex, Centocor, conform, COSO, criteria, debt, decline, Deferral, Deferred, deficit, detect, deteriorate, dose, doubtful, due, extensive, external, Extra, Fee, firm, Foreign, Framework, Gain, HBr, hyperactivity, inadequate, inherent, Insurance, Joseph, Kaye, lack, launched, Leadership, Letter, Life, LLP, LO, lost, low, matter, migraine, pediatric, rebate, reclassified, registered, reliability, relinquished, reserve, Scodari, site, Supplemental, systematic, table, Team, term, Treadway, VELCADE, Vioxx, Web
Filing tables
Filing exhibits
- 10-K Annual report
- 10 Deferred Fee Plan for Directors (As Amended)
- 10 Summary of Compensation
- 12 Statement of Computation of Ratio of Earnings
- 13 Pages 28-66 of Annual Report to Shareholders
- 21 Subsidiaries
- 23 Consent of Independent Registered Public Accounting Firm
- 31 Certification
- 31 Certification
- 32 Certification
- 32 Certification
- 99 Cautionary Statement Pursuant to Private Securities
JNJ similar filings
External links